A group of Venrock Healthcare entities and two individual managers filed a Schedule 13G with the SEC on October 30, 2026, disclosing beneficial ownership of 8,861,763 ordinary shares of Entera Bio Ltd. as of October 23, 2026.

Key Highlights

  • Aggregate beneficial ownership: The seven reporting persons each report beneficial ownership of 8,861,763 ordinary shares of Entera Bio Ltd.
  • Percent of class: The reported stake represents 5.1% of Entera Bio's ordinary shares, based on 173,922,428 shares outstanding as of October 1, 2026.
  • Share breakdown: The filing discloses 3,891,972 shares held by VHCP III, 389,631 shares held by VHCP Co-Investment III, and 4,580,160 shares held by VHCP EG.
  • Voting and dispositive power: All seven reporting persons report zero sole voting or dispositive power and 8,861,763 shared voting and dispositive power each.
  • Individual reporting persons: Nimish Shah and Bong Y. Koh are identified as voting members of VHCP Management III and VHCP Management EG.
  • Triggering event date: The date of the event requiring the filing is stated as October 23, 2026.

Venrock Healthcare Group Reports Joint 5.1% Position in Entera Bio Ordinary Shares

According to the Schedule 13G filed October 30, 2026, seven reporting persons acting as a group disclosed beneficial ownership of ordinary shares of Entera Bio Ltd., an issuer whose shares carry a par value of NIS 0.0000769 and are identified by CUSIP number M40527109. The reporting persons are Venrock Healthcare Capital Partners III, L.P. ("VHCP III"), VHCP Co-Investment Holdings III, LLC ("VHCP Co-Investment III"), Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG"), VHCP Management III, LLC, VHCP Management EG, LLC, Nimish Shah, and Bong Y. Koh. All entities were organized in Delaware; Shah and Koh are United States citizens.

The filing states that the group's combined holdings consist of 3,891,972 ordinary shares held by VHCP III, 389,631 ordinary shares held by VHCP Co-Investment III, and 4,580,160 ordinary shares held by VHCP EG, totaling 8,861,763 shares. According to the filing, VHCP Management III serves as the general partner of VHCP III and the manager of VHCP Co-Investment III, while VHCP Management EG serves as the general partner of VHCP EG. Shah and Koh are identified as the voting members of both management entities.

The filing reports that the 5.1% ownership percentage is calculated based on 173,922,428 ordinary shares outstanding as of October 1, 2026, as reported in Entera Bio's definitive proxy statement filed with the SEC on October 14, 2026. Each reporting person discloses zero sole voting power and zero sole dispositive power, with all 8,861,763 shares held under shared voting and shared dispositive power. The reporting persons list business addresses in New York, New York and Palo Alto, California.

What Was Disclosed

A seven-member group led by Venrock Healthcare entities filed a Schedule 13G disclosing collective beneficial ownership of 8,861,763 ordinary shares of Entera Bio Ltd., representing 5.1% of the class, as of October 23, 2026.